Investor Yair Einhorn reports the metabolic drug developer is making a steep cut to its clinical pipeline. Details are thin, so check the source.
Recap by typeshit. Post by Yair Einhorn on X.
2:06:18
A live Q&A from FitFlavorFun taking viewer questions on Zepbound, Ozempic, Wegovy, retatrutide and Korglutide.
People familiar with the matter say the plan under review includes more safeguards for patients than first expected. A policy step worth watching.
Celebrity paparazzi item on Amanda Bynes stepping out in a miniskirt, framed around her reported Ozempic use. Little detail beyond the photos.
The show is collecting experiences from people microdosing GLP-1 drugs, including why they tried it and how they got the medication.
A hospital doctor walks through what these drugs do for weight management and diabetes care, and who might benefit from them.
The open-source tool analyzes and designs antimicrobial peptide sequences on an alpha-helical scaffold for membrane environments.
Loading…